Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Nord, Erik
1997.
Comment: Aggregating Health State Valuations.
Journal of Health Services Research & Policy,
Vol. 2,
Issue. 3,
p.
166.
Glick, Henry A.
Polsky, Daniel
Willke, Richard J.
and
Schulman, Kevin A.
1999.
A Comparison of Preference Assessment Instruments Used in a Clinical Trial.
Medical Decision Making,
Vol. 19,
Issue. 3,
p.
265.
Nord, Erik
Pinto, Jose Luis
Richardson, Jeff
Menzel, Paul
and
Ubel, Peter
1999.
Incorporating societal concerns for fairness in numerical valuations of health programmes.
Health Economics,
Vol. 8,
Issue. 1,
p.
25.
S�nb� Kristiansen, Ivar
Kristian Kvien, Tore
and
Nord, Erik
1999.
Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
Arthritis & Rheumatism,
Vol. 42,
Issue. 11,
p.
2293.
Nord, Erik
1999.
Towards Cost-Value Analysis in Health Care?.
Health Care Analysis,
Vol. 7,
Issue. 2,
p.
167.
Murray, Christopher J.L.
Evans, David B.
Acharya, Arnab
and
Baltussen, Rob M.P.M.
2000.
Development of WHO guidelines on generalized cost-effectiveness analysis.
Health Economics,
Vol. 9,
Issue. 3,
p.
235.
Neumann, Peter J.
Goldie, Sue J.
and
Weinstein, Milton C.
2000.
Preference-Based Measures in Economic Evaluation in Health Care.
Annual Review of Public Health,
Vol. 21,
Issue. 1,
p.
587.
Gulbrandsen, Nina
Wisløff, Finn
Nord, Erik
Lenhoff, Stig
Hjorth, Martin
and
Westin, Jan
2001.
Cost–utility analysis of high‐dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma.
European Journal of Haematology,
Vol. 66,
Issue. 5,
p.
328.
Nord, Erik
2001.
Health state values from multiattribute utility instruments need correction.
Annals of Medicine,
Vol. 33,
Issue. 5,
p.
371.
Sintonen, Harri
2001.
The 15D instrument of health-related quality of life: properties and applications.
Annals of Medicine,
Vol. 33,
Issue. 5,
p.
328.
Green, Colin
2001.
On the societal value of health care: what do we know about the person trade‐off technique?.
Health Economics,
Vol. 10,
Issue. 3,
p.
233.
Kristiansen, Ivar Sønbø
and
Kvien, Tore Kristian
2002.
Cost-effectiveness of replacing NSAIDs with coxibs: diclofenac and celecoxib in rheumatoid arthritis.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 2,
Issue. 3,
p.
229.
Earnshaw, Stephanie R.
Richter, Anke
Sorensen, Stephen W.
Hoerger, Thomas J.
Hicks, Katherine A.
Engelgau, Michael
Thompson, Ted
Venkat Narayan, K. M.
Williamson, David F.
Gregg, Edward
and
Zhang, Ping
2002.
Optimal Allocation of Resources across Four Interventions for Type 2 Diabetes.
Medical Decision Making,
Vol. 22,
Issue. 1_suppl,
p.
80.
Nord, Erik
Pinto, José Luis
Richardson, Jeff
Menzel, Paul
and
Ubel, Peter
2003.
Comments to ‘a note on cost‐value analysis’.
Health Economics,
Vol. 12,
Issue. 3,
p.
251.
Thoma, Achilleas
Khuthaila, Dana
Rockwell, Gloria
and
Veltri, Karen
2003.
Cost‐utility analysis comparing free and pedicled TRAM flap for breast reconstruction.
Microsurgery,
Vol. 23,
Issue. 4,
p.
287.
McKie, John
and
Richardson, Jeff
2003.
The Rule of Rescue.
Social Science & Medicine,
Vol. 56,
Issue. 12,
p.
2407.
Stigum, Hein
Strand, Terje
and
Magnus, Per
2003.
SHOULD RADON BE REDUCED IN HOMES? A COST-EFFECT ANALYSIS.
Health Physics,
Vol. 84,
Issue. 2,
p.
227.
Schwarzinger, Michaël
Lanoë, Jean‐Louis
Nord, Erik
and
Durand‐Zaleski, Isabelle
2004.
Lack of multiplicative transitivity in person trade‐off responses.
Health Economics,
Vol. 13,
Issue. 2,
p.
171.
Thoma, Achilleas
Haines, Ted
Veltri, Karen
Goldsmith, Charlie H
O'brien, Bernie J
and
Quartly, Caroline
2004.
A Methodological Guide to Performing a Cost-Utility Study Comparing Surgical Techniques.
Canadian Journal of Plastic Surgery,
Vol. 12,
Issue. 4,
p.
179.
Brinsmead, Gina
and
Williams, Alan
2004.
Evaluating Pharmaceuticals for Health Policy and Reimbursement.
p.
105.